Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,472
Recruiting: 1,283
Ph III recruiting: 130
Growth YoY: +4.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,642)

clinicaltrialsPublishedShowing 4,501–4,550 of 4,946 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00536575	Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients	completed	Phase 1 / Phase 2	13	SCRI Development Innovations, LLCOTHER	1	Feb 27, 2013	clinicaltrials
NCT00005811	Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment	completed	Phase 2	77	National Cancer Institute (NCI)NIH	1	Feb 21, 2013	clinicaltrials